Breast cancer is not a single disease, it’s a group of conditions that differ based on where in the breast they originate, how they grow, and how they behave. Understanding the different types of breast cancer can help patients make sense of a diagnosis and better understand the treatment path recommended by their Best Breast Cancer Surgeon and broader care team. This article walks through the most common and clinically significant types of breast cancer.
How Breast Cancer Is Classified
Breast cancer is generally categorized in a few different ways:
- By location of origin: where in the breast tissue the cancer starts (ducts, lobules, or other tissue)
- By invasiveness: whether the cancer has spread beyond its point of origin into surrounding tissue
- By hormone receptor and genetic status: such as estrogen receptor (ER), progesterone receptor (PR), and HER2 status, which affect treatment decisions
This article focuses primarily on classification by location and invasiveness, since that’s often the first distinction made at diagnosis.
Ductal Carcinoma
Ductal carcinoma is the most common type of breast cancer, accounting for the majority of diagnoses. It begins in the milk ducts, the tubes that carry milk from the lobules to the nipple.
Ductal Carcinoma In Situ (DCIS)
DCIS is considered a non-invasive or “pre-invasive” form of breast cancer. The abnormal cells are confined to the lining of the milk duct and have not spread into surrounding breast tissue. While DCIS itself is not life-threatening, it is treated because it can, over time, progress into invasive cancer if left untreated. It’s often detected through routine mammography, since it typically doesn’t cause a noticeable lump.
Invasive Ductal Carcinoma (IDC)
IDC is the most common form of invasive breast cancer, making up a large share of all breast cancer diagnoses. In this type, cancer cells break through the wall of the milk duct and invade the surrounding breast tissue. From there, it can potentially spread to nearby lymph nodes and other parts of the body if not caught and treated early, which is why prompt evaluation by a Surgical Oncologist is important once IDC is suspected.
Lobular Carcinoma
Lobular carcinoma begins in the lobules, the glands responsible for producing milk.
Lobular Carcinoma In Situ (LCIS)
LCIS is not technically classified as cancer but rather as a marker of increased risk. The abnormal cells stay contained within the lobules and don’t invade surrounding tissue. However, having LCIS increases the likelihood of developing invasive breast cancer later in life, in either breast, so it often leads to closer monitoring or, in some cases, preventive strategies.
Invasive Lobular Carcinoma (ILC)
ILC is the second most common type of invasive breast cancer. Unlike ductal carcinoma, ILC can be harder to detect on a mammogram because it tends to grow in a subtle, single-file pattern rather than forming a firm lump, which can sometimes delay diagnosis. It may also be more likely to occur in both breasts compared to other types.
Inflammatory Breast Cancer (IBC)
Inflammatory breast cancer is a rare but aggressive form of breast cancer, accounting for a small percentage of cases. Unlike most breast cancers, IBC often doesn’t present as a distinct lump. Instead, cancer cells block lymphatic vessels in the skin of the breast, leading to symptoms that can resemble an infection, such as:
- Redness or discoloration covering a significant portion of the breast
- Swelling and warmth in the breast
- Skin that appears pitted or dimpled, similar to an orange peel (peau d’orange)
- Rapid changes in breast size or shape
- Itching or tenderness
Because these symptoms can mimic mastitis or another benign condition, IBC is sometimes misdiagnosed initially, which is part of why it tends to be identified at a more advanced stage. It also tends to grow and spread more quickly than other types, requiring prompt and aggressive treatment coordinated by an experienced Surgical Oncologist.
Other Notable Types of Breast Cancer
Triple-Negative Breast Cancer (TNBC)
This subtype is defined by what it lacks: TNBC tests negative for estrogen receptors, progesterone receptors, and HER2 protein. Because it doesn’t respond to hormone therapy or HER2-targeted treatments, it’s often treated with chemotherapy, surgery, and radiation. TNBC tends to grow faster and is more common in younger women, women who are BRCA1 carriers, and Black women.
HER2-Positive Breast Cancer
This type of cancer has higher-than-normal levels of the HER2 protein, which promotes the growth of cancer cells. While HER2-positive cancers were once associated with more aggressive behavior, the development of HER2-targeted therapies has significantly improved outcomes for patients with this subtype.
Paget Disease of the Breast
This rare form of breast cancer affects the skin of the nipple and areola, often causing scaly, red, itchy, or flaky skin resembling eczema. It’s frequently associated with an underlying ductal carcinoma, either in situ or invasive.
Phyllodes Tumors
Though rare and most often benign, phyllodes tumors can occasionally be malignant. These tumors develop in the connective tissue of the breast rather than the ducts or lobules and tend to grow quickly, though they rarely spread beyond the breast.
Metaplastic Breast Cancer
A rare and often aggressive subtype in which the cancer cells show characteristics of both ductal cells and other cell types, such as skin or muscle cells. It’s frequently triple-negative and can be more resistant to standard chemotherapy.
Why Type Matters for Treatment
The specific type of breast cancer, along with its stage, hormone receptor status, and genetic markers, plays a major role in determining the most appropriate treatment plan. For example:
- Non-invasive types like DCIS may be treated with surgery alone or surgery plus radiation
- Invasive types often require a combination of surgery, radiation, chemotherapy, and/or hormone or targeted therapy
- Inflammatory breast cancer typically requires a more aggressive, multi-pronged treatment approach starting with chemotherapy before surgery
- Hormone receptor-positive cancers may respond well to hormone-blocking medications
- HER2-positive cancers benefit from targeted biologic therapies
Getting an Accurate Diagnosis
Because treatment varies so significantly by type, an accurate diagnosis is essential. This typically involves:
- Imaging (mammogram, ultrasound, or MRI)
- Biopsy to examine tissue samples
- Pathology testing to determine hormone receptor and HER2 status
- Sometimes genetic testing to check for inherited mutations like BRCA1 or BRCA2
Final Thoughts
Breast cancer encompasses a wide range of conditions, each with its own characteristics, risk factors, and treatment considerations. Understanding which type of breast cancer is involved is a critical first step in building an effective, personalized treatment plan. Anyone diagnosed with breast cancer should work closely with a Best Breast Cancer Surgeon and their broader oncology team to fully understand their specific diagnosis and the reasoning behind their recommended treatment path.